We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCOM icon
2501
Trip.com Group
TCOM
$29.1B
$12.3K ﹤0.01%
164
-461
-74% -$30.8K
CNOB icon
2502
Center Bancorp
CNOB
$1.78B
$12.3K ﹤0.01%
+497
New +$12.3K
LXU icon
2503
LSB Industries
LXU
$693M
$12.2K ﹤0.01%
1,548
+1,253
+425% +$10.2K
FNWD icon
2504
Finward Bancorp
FNWD
$193M
$12.2K ﹤0.01%
+379
New +$11.3K
IPI icon
2505
Intrepid Potash
IPI
$469M
$12.1K ﹤0.01%
397
+263
+196% +$8.28K
IDE
2506
Voya Infrastructure, Industrials and Materials Fund
IDE
$198M
$12.1K ﹤0.01%
+1,000
New +$12.1K
GES
2507
DELISTED
Guess Inc
GES
$12.1K ﹤0.01%
+725
New +$10.7K
NBBK icon
2508
NB Bancorp
NBBK
$989M
$12.1K ﹤0.01%
+683
New +$12.5K
LGIH icon
2509
LGI Homes
LGIH
$1.4B
$12K ﹤0.01%
233
+184
+376% +$10.7K
BTSG icon
2510
BrightSpring Health Services
BTSG
$12.4B
$12K ﹤0.01%
+406
New +$9.44K
AMAL icon
2511
Amalgamated Financial
AMAL
$1.49B
$12K ﹤0.01%
+442
New +$13.1K
CHRS icon
2512
Coherus Oncology
CHRS
$196M
$12K ﹤0.01%
+7,311
New +$8.13K
PECO icon
2513
Phillips Edison & Co
PECO
$5.24B
$11.9K ﹤0.01%
348
+191
+122% +$6.62K
OOMA icon
2514
Ooma
OOMA
$604M
$11.9K ﹤0.01%
994
+852
+600% +$10.4K
CALX icon
2515
Calix
CALX
$2.39B
$11.9K ﹤0.01%
+194
New +$11.2K
ACEL icon
2516
Accel Entertainment
ACEL
$987M
$11.9K ﹤0.01%
+1,074
New +$12.6K
EPC icon
2517
Edgewell Personal Care
EPC
$1.31B
$11.8K ﹤0.01%
+581
New +$13.6K
KALV
2518
DELISTED
KalVista Pharmaceuticals
KALV
$11.8K ﹤0.01%
+971
New +$13.4K
WRN
2519
Western Copper and Gold
WRN
$544M
$11.8K ﹤0.01%
+6,000
New +$8.54K
LFVN icon
2520
LifeVantage
LFVN
$85.3M
$11.8K ﹤0.01%
1,211
+171
+16% +$2.14K
ABFL
2521
Abacus FCF Leaders ETF
ABFL
$537M
$11.7K ﹤0.01%
163
LGND icon
2522
Ligand Pharmaceuticals
LGND
$5.88B
$11.7K ﹤0.01%
+66
New +$9.81K
BL icon
2523
BlackLine
BL
$1.72B
$11.7K ﹤0.01%
220
+212
+2,650% +$11.5K
CE icon
2524
Celanese
CE
$4.82B
$11.7K ﹤0.01%
277
+221
+395% +$11K
DLS icon
2525
WisdomTree International SmallCap Dividend Fund
DLS
$1.08B
$11.7K ﹤0.01%
146
-1
-0.7% -$78

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.